| Code | 99814 | ||||||||||
| MA number | 85/0703/94-S | ||||||||||
| Product Form: | cps 100x400 mg | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | National | ||||||||||
| MAH, country: | Phoenix Labs, Ireland | ||||||||||
| Therapeutic Class: | 85 - VENOPHARMACA, ANTIVARICOSA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 8(3) application - new active substance |
| MA issued: | 31.10.1994 |
| SPC: |
SPC_Glyvenol 400_12.2020.doc
|
| PIL: |
PIL_Glyvenol 400_07.2021.pdf
|
| Safety feature | Yes |
| Data update: | 04.10.2018 |
